Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » Using Lipid Based Delivery For Early Phase Development

Venerated And Vital: Using Lipid Based Delivery For Fast And Efficient Early Phase Development

Summary: Introduced to the pharmaceutical industry decades ago, lipid-based drug delivery systems are the most well-studied and widely utilized technology among all available bioavailability enhancement technologies.

  • Lipid-based drug delivery systems have delivered more than 60 unique drug molecules to market – and counting.
  • With today’s increasingly complex new molecules emerging from R&D, optimizing bioavailability for early phase molecules is critical to their success.

Not only do lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules, they also allow for efficient and scalable dose formulation solutions which can accelerate progress to clinic and beyond, especially for orphan and breakthrough therapies.

Click here to watch the Webinar